Warning: unlink(/home/nspna_com/www/__cache/2026/02/20/a5b8c3ca6029d166d7791443c32b5cce): No such file or directory in /home/nspna_com/www/__lib/class.URLCache.php on line 127
Warning: unlink(/home/nspna_com/www/__cache/2026/02/20/c8b14f7d11f9cf96b6ea69540fe03260): No such file or directory in /home/nspna_com/www/__lib/class.URLCache.php on line 127
Warning: unlink(/home/nspna_com/www/__cache/2026/02/20/e11eb34508a9ebdc9532391bd8d40e07): No such file or directory in /home/nspna_com/www/__lib/class.URLCache.php on line 127
뉴스-NSP통신
![[NSPAD]삼성전자](https://file.nspna.com/ad/T01_samsung_5043.gif)
![[NSP7컷]인터넷은행의 혁신적인 배신](https://file.nspna.com/news/2023/05/30/photo_20230530123951_639759_0.jpg "[NSP7컷]인터넷은행의 혁신적인 배신")
![[NSP PHOTO][재계·산업 업계동향]한화오션·SK이노베이션 조선·LNG 확대…AI·조직문화 혁신 병행](https://file.nspna.com/news/2026/02/19/20260219165815_803395_0.png)
![[NSP PHOTO][제약·바이오업계동향]셀트리온, 임상데이터 공개·유한양행, 다국가 시험 착수…신약개발 속도](https://file.nspna.com/news/2026/02/19/20260219163524_803390_0.png)
![[NSP PHOTO][업앤다운]제약주 상승…부광약품↑· 모아라이프플러스↓](https://file.nspna.com/news/2026/02/19/20260219161110_803377_0.png)
![[NSP PHOTO][들어보니]유한양행, 알레르기 질환 치료제 임상2상 착수…유효·안전성 객관적 평가 예정](https://file.nspna.com/news/2026/02/19/20260219152942_803352_0.jpg)
![[NSP PHOTO][들어보니]코스닥 대규모 퇴출 예고…시장 건전성 강화 vs 고의 상폐 악용 우려](https://file.nspna.com/news/2026/02/12/20260212160718_802826_0.png)
![[NSP PHOTO][들어보니]KT 6G 경쟁력, 속도에 AI 더해진다…표준 선점 경쟁 본격화](https://file.nspna.com/news/2026/02/11/20260211171637_802579_0.jpg)